Regulated Bioanalysis

Push the Limits of Regulated Bioanalysis

 If the past 30 years of our rich pedigree in quantitative bioanalysis have proven one thing, it is that AB SCIEX has constantly been pushing the limits of what is possible in regulated bioanalysis.  From the introduction of the API III Triple Quad which defined quantitative bioanalysis, to the barrier breaking performance levels of the QTRAP® 5500 and Triple Quad™5500 Systems, AB SCIEX has maintained its vision: providing the drug discovery & development industry with the technology they need to push the limits of discovery & development and accelerate todays discoveries into tomorrows breakthrough treatments.

With increasingly complex drug candidates comes increasingly challenging bioanalytical assays. The bold advancements in performance and versatility of the Triple Quad™ 5500 and QTRAP® 5500 Systems are clear examples of our commitment to pushing the limits of what is possible in quantitation. Our recent advancements in MRM³ Quantitation and Dried Blood Spot analysis can help you push the limits of what is possible in regulated bioanalysis.